These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 23146429)
1. Short imidazolium chains effectively clear fungal biofilm in keratitis treatment. Liu L; Wu H; Riduan SN; Ying JY; Zhang Y Biomaterials; 2013 Jan; 34(4):1018-23. PubMed ID: 23146429 [TBL] [Abstract][Full Text] [Related]
2. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. Mahdy RA; Nada WM; Wageh MM; Kader MA; Saleh MM; Alswad MM Cutan Ocul Toxicol; 2010 Sep; 29(3):193-7. PubMed ID: 20462395 [TBL] [Abstract][Full Text] [Related]
3. Synthetic β-sheet forming peptide amphiphiles for treatment of fungal keratitis. Wu H; Ong ZY; Liu S; Li Y; Wiradharma N; Yang YY; Ying JY Biomaterials; 2015 Mar; 43():44-9. PubMed ID: 25591960 [TBL] [Abstract][Full Text] [Related]
4. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067 [TBL] [Abstract][Full Text] [Related]
5. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility. Zhang X; Sun X; Wang Z; Zhang Y; Hou W Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7774-8. PubMed ID: 23099491 [TBL] [Abstract][Full Text] [Related]
6. [Keratomycosis - Therapy Standards and New Developments]. Behrens-Baumann W; Finis D; MacKenzie C; Roth M; Geerling G Klin Monbl Augenheilkd; 2015 Jun; 232(6):754-64. PubMed ID: 26084964 [TBL] [Abstract][Full Text] [Related]
7. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962 [TBL] [Abstract][Full Text] [Related]
8. [Fungal keratitis at the Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts: retrospective study of 19 cases]. Rondeau N; Bourcier T; Chaumeil C; Borderie V; Touzeau O; Scat Y; Thomas F; Baudouin C; Nordmann JP; Laroche L J Fr Ophtalmol; 2002 Nov; 25(9):890-6. PubMed ID: 12515932 [TBL] [Abstract][Full Text] [Related]
9. Short Synthetic α-Helical-Forming Peptide Amphiphiles for Fungal Keratitis Treatment In Vivo. Wu H; Liu S; Wiradharma N; Ong ZY; Li Y; Yang YY; Ying JY Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28081296 [TBL] [Abstract][Full Text] [Related]
10. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits. Pleyer U; Legmann A; Mondino BJ; Lee DA Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224 [TBL] [Abstract][Full Text] [Related]
16. Keratitis due to Cephaliophora irregularis Thaxter. Mathews MS; Kuriakose T J Med Vet Mycol; 1995; 33(5):359-60. PubMed ID: 8544090 [TBL] [Abstract][Full Text] [Related]
17. Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761 [TBL] [Abstract][Full Text] [Related]
18. A new long-acting liposomal topical antifungal formula: human clinical study. Abdel-Rhaman MS; Soliman W; Habib F; Fathalla D Cornea; 2012 Feb; 31(2):126-9. PubMed ID: 22138587 [TBL] [Abstract][Full Text] [Related]
19. Wickerhamomyces anomalus fungal keratitis responds to topical treatment with antifungal micafungin. Kamoshita M; Matsumoto Y; Nishimura K; Katono Y; Murata M; Ozawa Y; Shimmura S; Tsubota K J Infect Chemother; 2015 Feb; 21(2):141-3. PubMed ID: 25239058 [TBL] [Abstract][Full Text] [Related]
20. Differences in response in vivo to amphotericin B among Candida albicans strains. O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]